Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Goodwill: 2019-2024

Historic Goodwill for Silence Therapeutics (SLN) over the last 6 years, with Dec 2024 value amounting to $9.4 million.

  • Silence Therapeutics' Goodwill rose 12.99% to $10.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.6 million, marking a year-over-year increase of 12.99%. This contributed to the annual value of $9.4 million for FY2024, which is 5.90% down from last year.
  • As of FY2024, Silence Therapeutics' Goodwill stood at $9.4 million, which was down 5.90% from $10.0 million recorded in FY2023.
  • Over the past 5 years, Silence Therapeutics' Goodwill peaked at $10.4 million during FY2021, and registered a low of $9.4 million during FY2024.
  • For the 3-year period, Silence Therapeutics' Goodwill averaged around $9.7 million, with its median value being $9.7 million (2022).
  • As far as peak fluctuations go, Silence Therapeutics' Goodwill climbed by 6.23% in 2020, and later declined by 7.30% in 2022.
  • Silence Therapeutics' Goodwill (Yearly) stood at $10.4 million in 2020, then grew by 0.11% to $10.4 million in 2021, then decreased by 7.30% to $9.7 million in 2022, then increased by 3.08% to $10.0 million in 2023, then dropped by 5.90% to $9.4 million in 2024.